CLDN1 and cancer: Because the AKR superfamily is involved in anticancer drug resistance in cancer cells [14,39], the viability of cancer cells was assessed after exposure to etoposide, doxorubicin, and daunorubicin to clarify the effect of Cldn1 expression on drug resistance.